Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Bertram I. Rowland

by Susan J. Ainsworth
January 24, 2011 | A version of this story appeared in Volume 89, Issue 4

Bertram I. Rowland, 80, a chemical and biotechnology industry patent attorney, died of pancreas cancer on Oct. 28, 2010.

Born in New York City, Rowland received a B.S. in chemistry from the University of California, Los Angeles, in 1950 and a Ph.D. in physical organic chemistry from the University of Washington, Seattle, in 1954. He conducted postdoctoral research at Harvard University and attended Stanford Law School before earning a J.D. from George Washington University Law School in 1961.

Rowland began his law career as a patent agent in the DuPont Patent Training Program. He then worked as a supervisory patent attorney for Chevron Research before becoming a partner in a number of law firms and acting as general counsel for various biotech companies.

He supported the start-up of numerous biotech firms, including SyStemix and Pharmacopoeia. The Cohen and Boyer cloning patents, which are three pioneering gene-splicing patents, were among the more than 500 patents he wrote and prosecuted. He was an emeritus member of ACS, joining in 1954.

Rowland had a lifelong love of mountains, climbing Mount Kilimanjaro at age 70. He and his wife of 36 years, Susan, visited six of the seven continents. Rowland became a master gardener in 2009 and remained an avid tennis player until just before his death.

In addition to his wife, he is survived by his three children, Shawn, Celia, and Kevin Rowland, from his first marriage to Patricia Butterfield.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.